Briefing on ARTS to Secretary Hazel October 2017

Similar documents
ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS) PROGRAM UPDATE

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS)

VIRGINIA MEDICAID ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS) OFFICE BASED OPIOID PROVIDER (OBOT) PAYMENT MODEL 3 rd Annual Mental Health Summit

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

VIRGINIA MEDICAID PERSPECTIVE ON BEST PRACTICES IN THE TREATMENT OF OPIOID USE DISORDER

ADDICTION AND RECOVERY OPIOID CRISIS

PERSPECTIVE FROM VIRGINIA: SUCCESS ADDRESSING THE OPIOID CRISIS THROUGH MEDICAID ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS)

Addiction and Recovery Treatment Services (ARTS) Reimbursement Structure

Medicaid and the Opioid Crisis

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

CLINICAL POLICY Clinical Policy: Extended Release Opioid Analgesics

Virginia Medicaid Peer Support Services UM Guideline

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

DMAS UPDATE ON GAP PROGRAM. Cindi B. Jones, Director, DMAS House Appropriations Committee September 18, 2017

Opioid Management of Chronic (Non- Cancer) Pain

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

From Medicaid Transformation Approved Project Toolkit, June 2017

State Opioid Response (SOR) Grant

BUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES

Addressing the Opioid Epidemic through a Public Health Lens

See Important Reminder at the end of this policy for important regulatory and legal information.

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Public Policy Statement on the Regulation of Office-Based Opioid Treatment

Prepublication Requirements

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Addressing the Opioid Crisis Policy Recommendations

Aetna s Initiative on the Opioid Epidemic

The Opioid Crisis: Effectiveness of State Responses

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

MAGELLAN VA MEDICAID/DMAS RATES

See Important Reminder at the end of this policy for important regulatory and legal information.

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Oregon Opioid Overdose Prevention Initiative

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.19

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Curbing Prescription Drug Abuse in Medicaid

Opioid Treatment Program Reimbursement Re-bundling Proposal

MAGELLAN VA MEDICAID/DMAS RATES

See Important Reminder at the end of this policy for important regulatory and legal information.

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.18

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

TN Opioid Program. Erica Schlesinger, Pharm.D

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

Opioid Analgesic Treatment Worksheet

The CARA & Buprenorphine Prescribing for APNs & PAs

Opioid Analgesic Treatment Worksheet

Addiction Recovery Treatment Services (ARTS): Billing Best Practices. December 2017

Opioid epidemic and PEHP

Opiate Use Disorder and Opiate Overdose

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

Strategic Plan

Frequently Asked Questions about Florida s Opioid STR Grant

RI Centers of Excellence for the

Opioid Prescribing Improvement Program

HHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members:

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Fighting Today s Opioid Epidemic

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Prescription Monitoring Program (PMP)

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)

Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

Division of Mental Health and Addiction Services

Clinical Policy: Buprenorphine-Naloxone (Bunavail, Suboxone, Zubsolv) Reference Number: CP.PMN.81 Effective Date: Last Review Date: 02.

TESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown

Management Options for Opioid Dependence:

MICIS 2017 REPORT January 1 - December 31, 2017

SAMHSA/HHS: An Update on the Opioid Crisis

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018

See Important Reminder at the end of this policy for important regulatory and legal information.

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

Opioid Task Force Kick-Off Meeting. February 29, 2016

Changing Course: statewide efforts to combat the opioid epidemic in California

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

New Guidelines for Prescribing Opioids for Chronic Pain

Clinical Policy: Naltrexone (Vivitrol) Reference Number: CP.PHAR.96 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Policy: Naltrexone (Vivitrol) Reference Number: CP.PHAR.96 Effective Date: Last Review Date: Line of Business: Medicaid

PHMC Integrated Health Services Overview

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS

AETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization

Governor Raimondo s Task Force on Overdose Prevention and Intervention May 9, 2018

Transcription:

Agenda -DMAS -DBHDS -VDH -Final discussion Briefing on ARTS to Secretary Hazel October 2017 http://www.dmas.virginia.gov/ 1

Medicaid Addiction and Recovery Treatment Services (ARTS) Partial Hospitalization Intensive Outpatient Programs Opioid Treatment Case Management Magellan will continue to cover community-based substance use disorder treatment services for feefor-service members Residential Treatment Inpatient Detox Effective April 1, 2017 Addiction and Recovery Treatment Services (ARTS) Peer Recovery Supports effective July 1, 2017 Peer Recovery Supports Crisis Intervention All Community- Based SUD Services will be Covered by Managed Care Plans A fully integrated Physical and Behavioral Health Continuum of Care http://www.dmas.virginia.gov/ 2

Budgeted Costs for ARTS Benefit Funding Included in 2016 Appropriations Act as Substance Use Disorder funding: 2017 2018 $2.5 million GF ($5 million total funds) $8.3 million GF ($16.6 million total funds) This year's Medicaid forecast is not changing these projected costs. http://www.dmas.virginia.gov/ 3

Health Systems Asks for Health Systems and Health Plans Add inpatient detox beds and Addiction Detox Units Add DBHDS Detox License to Inpatient Psych Units Develop Intensive Outpatient and Partial Hospitalization Programs Provide integrated MAT in outpatient clinics buprenorphine-waivered physicians with integrated behavioral health providers and peer supports Encourage physicians and behavioral health providers to attend VDH Addiction Disease Management sessions Commercial Health Plans Implement CDC Opioid Prescribing Guidelines for Chronic Pain that FFS implemented on 7/1/16 and Medicaid plans will implement 12/1/16 Offer similar rates for addiction treatment as Medicaid plans to catalyze expansion of addiction treatment http://www.dmas.virginia.gov/ 4

Payment Model for Office-Based Opioid Treatment Providers Service Description Codes Physician Visit Counseling H0014 MAT Induction CPT E/M Code: Established Patient H0020 Opioid Treatment - individual, group counseling and family therapy / prescribing and medication oversight Care Coordination G9012 Substance Abuse Care Coordination Peer Supports H0038 Peer Support Services S9445 Peer Patient Education Individual S9446 Peer Patient Education - Group Urine Drug Screen G0477-G0483 Examples: Hepatitis B Test (86704), Hepatitis C test (86803), HIV Labs Test (86703), Pregnancy Test (81025), PPD (86585) http://www.dmas.virginia.gov/ 5

OBOT Providers will be Credentialed by Health Plans Care Team Requirements Buprenorphine-waivered physician may practice in a variety of practice settings including primary care clinics, outpatient health system clinics, psychiatry clinics, FQHCs, CSBs, Health Departments, and physician s offices On site licensed behavioral health provider providing counseling to patients receiving buprenorphine MAT Requirements Buprenorphine monoproduct prescribed only to pregnant women. All other patients receive buprenorphine/naloxone or naltrexone products Maximum daily buprenorphine/naloxone dose 16 mg unless documentation of compelling clinical rationale for higher dose up to maximum of 24 mg No tolerance to other opioids, soma, stimulants, or benzodiazepines except for patients already on benzodiazepines for 3 months during a relapse or tapering plan http://www.dmas.virginia.gov/ 6

OBOT Providers will be Credentialed by Health Plans Risk Management and Adherence Monitoring Requirements Random urine drug screens, a minimum of 8 times per year. Virginia Prescription Monitoring Program checked at least quarterly. Opioid overdose prevention education including naloxone. Patients seen at least weekly when initiating treatment. Periodic utilization of unused medication and opened medication wrapper counts Benefits No PA required for buprenorphine or buprenorphine/naloxone Buprenorphine-waivered physician in the OBOT can bill all Medicaid plans for substance abuse care coordination code (monthly per member payment) for members with moderate to severe opioid use disorder receiving MAT. Can bill for Certified Peer Recovery Support specialists http://www.dmas.virginia.gov/ 7

Buprenorphine Prior Authorization Requirements Uniform Requirements Adopted by FFS and Managed Care Plans Diagnosis of Opioid Use Disorder, and > 16 years of age; and Prescriber s personal DEA and XDEA numbers are required; and Individual is participating is psychosocial counseling Maximum of 16 mg per day Initial authorization for 3 months; subsequent authorizations for 6 months No set time limit or duration of treatment Buprenorphine only products for pregnant women Patient is locked-in to prescribing physician and dispensing pharmacy No concurrent use with benzodiazepines, tramadol, carisoprodol, other opiates or stimulants Urine drug testing at least 4 times per 6 months http://www.dmas.virginia.gov/ 8

Implementation of CDC Guidelines for Prescribing Opioids Uniform, Stream-lined Prior Authorization Forms for All Short acting opioids > 14 days or 90 MME and long-acting opioids Will require PMP check and urine drug screen Increase access to Naloxone Available without PA and no quantity limits Naloxone injection and Naloxone nasal spray (Narcan ) Include non-opioid pain relievers on all MCO formularies without PA Lidocaine patches Capsaisin topical gel SNRIs including duloxetine Gabapentin and pregabalin (Lyrica ) NSAIDs including oral and topicals (diclofenac gel) Baclofen Tricyclic antidepressants (TCAs) Buprenorphine patches and buccal film for pain http://www.dmas.virginia.gov/ 9

Implementation of CDC Guidelines for Prescribing Opioids Uniform Quantity Limits (QL) for Short and Long-acting Opioids QL based on maximum of 90 MME (morphine milligram equivalents) PA required for any individual drug dose > 90 MME or cumulative dosage > 120 MME Concomitant use of benzodiazepine with opioid will trigger a PA Provider and Member Education Prescriber Letters Identify patients receiving benzos and opioids concomitantly Identify patients receiving >90 MME individual drug opioid doses Identify patients receiving >120 MME cumulative opioid doses Member Letters Identify members that meet PUMS 2 criteria and provide lock-in information or educational materials regarding opioid use http://www.dmas.virginia.gov/ 10

Aligning ASAM Criteria with DBHDS Licensing Requirements http://www.dmas.virginia.gov/ 11

ASAM Training Offerings Two Day Skill Building (10 trainings total) Ten two-day skill building sessions intended primarily for those providing assessments, designing and implementing programs, providing case management services, and managing quality assurance. Sessions are limited to 40 participants. each. One Day Administrative Sessions (2 Total) Two one-day sessions intended for nonclinical managers, such as CEOs, CFOs, and CIOs. One Day Coach Trainings (2 Total) Two one-day sessions to train coaches who will provide ongoing continuity to assure that Virginia providers are consistently utilizing the ASAM Criteria Registration Fees $50 per person for CSBs and contract agencies $200 per person for MCOs and contract providers. The ASAM Criteria, 3rd Edition, www.asamcriteria.org Up to three participants can share a copy. http://www.dmas.virginia.gov/ 12

ASAM TWO DAY TRAINING SCHEDULE DATE LOCATION REGISTRATION November 1-2, 2016 November 3-4, 2016 VA Housing Development Authority Dorey Park Recreation Center, Henrico TRAINING FULL TRAINING FULL December 5-6, 2016 Fairlington Center, Arlington OPEN December 7-8, 2016 Northern VA, TBA OPEN January 3-4, 2017 Southwest VA, TBA OPEN January 5-6, 2017 Southwest VA, TBA OPEN January 31-February 1, 2017 Region Ten CSB, Charlottesville, VA OPEN February 2-3, 2017 The Cove, Winchester, VA OPEN February 27-23, 2017 Tidewater Area, TBA OPEN March 1-2, 2017 Tidewater Area, TBA OPEN http://www.dmas.virginia.gov/ 13

DBHDS Certified Peer Recovery Specialists (CPRS) Peer Certification HB 583 (2016) authorizes DBHDS Commissioner to certify individuals as peer providers in accordance with regulations adopted by the Board of Behavioral Health and Developmental Services. 2016 GA Appropriations Act directed DBHDS to promulgate emergency regulations for implementing the CPRS program and designation. DBHDS is in the process of developing a curriculum for Certified Peer Recovery Specialists (CPRS). Curriculum is expected to be established by January 2017. DBHDS is developing CPRS training timelines to support the implementation of peer services in the ARTS Waiver, for July 1, 2017. CPRS Train the Trainer sessions will begin in the spring of 2017 and will focus on the 5 regions to ensure broad availability and statewide workforce development. http://www.dmas.virginia.gov/ 14

DBHDS Certified Peer Recovery Specialists (CPRS) CPRS Structure and Development DBHDS is working with DHP and DMAS to develop regulations on the certification of peer recovery specialists. DBHDS is promulgating regulations that define the educational and experience requirements for certification, as well as certification bodies that will be accepted in Virginia. Proposed legislation and subsequent regulations will institute the requirement for CPRS to register with DHP and establish DHP authority to renew registration, investigate complaints, and implement any disciplinary actions. Registration will be required for a CPRS to be eligible for the payment of services by DMAS. http://www.dmas.virginia.gov/ 15

Health Systems DBHDS Asks Consider developing peer support programs in Emergency Department settings Implement CDC Opioid Prescribing Guidelines Encourage behavioral health providers to become ARTS providers Licensingadminsupport@dbhds.virginia.gov or 804-786-1747 Encourage ARTS providers (and those who will become ARTS providers) to attend ARTS ASAM trainings. http://www.dmas.virginia.gov/ 16

Addiction Disease Management Removing the Barriers for Integration and Application into Outpatient Clinical Practice Statewide Trainings for Healthcare, Behavioral Health, and Clinical Administration Professionals Statewide trainings within the 7 MCO regions: January 2016 to April 2017 Intended Audience: Practicing MDs/DOs, APNs, PAs, medical students, behavioral health professionals, substance abuse professionals, and administrators supporting provider clinical practice Content Virginia Medicaid s Addiction and Recovery Treatment Services (ARTS) new benefit; Assessment, screening, and monitoring of the integrated care patient at risk for, or with a history of, addiction Discovery of addiction as an underlying disease Integrated outpatient clinical practice and behavioral health care interventions for addiction disease management (ADM) Specialty track content for removing barriers and challenges to integration, coordination, and operational practice National framework content for obtaining the waiver to prescribe buprenorphine Development of a seamless OBOT primary care, behavioral health, and business model Framework Integration of ASAM criteria; Utilization of PCSS MAT criteria; Meets the requirement of the federal DATA 2000 law Physicians will complete the 8 hour SAMSHA funded Provider Clinical Support System: MAT criteria online and in-person hours to meet the requirement for providers to obtain the waiver to prescribe buprenorphine in their practice for treatment of opioid addiction. Free CMEs available for online and live trainings, including Virginia specific content http://www.dmas.virginia.gov/ 17

Association Meeting Presentations: Psychiatric Society of Virginia: October 2016 Medical Society of Virginia: October 2016 Community Care Network of VA October 2016 Va Academy of Family Physicians: February 2017 Specialty Trainer Expert Areas: Medical Behavioral Health Administrative Training Areas: Medical: Clinical and business delivery Behavioral Health: Primary to BH Integration Administrative: Operations Training Opportunities October 2016: ADM Sneak Peek Key SME experts to provide a Sneak Peak on the benefits and barriers to implementing ADM in an office setting, and on state level resources for the provider team November 2016: ADM Train-the-Trainer Model In each MCO region, selected champions will be trained to target and to educate local physicians, behavioral health providers, and administrators in the ADM curricula January-April 2017: ADM Train-the-Provider Model Approximately 4 trainings will be hosted in each of the 7 MCO regions Anticipated Reach: Approximately 300 providers. http://www.dmas.virginia.gov/ 18

VDH Addiction Workgroup Purpose: To convene VDH staff in an effort to analyze current policy, program, intervention, and data management related to the Opioid Epidemic and Addiction in the Commonwealth. Workgroup meets approximately every 6 weeks VDH Addiction Workgroup participants: OEpi, OCME, OEMS, OHE, OFHS, OCOM, ORCE Invited guests: include other state agencies DBHDS, OHP, Fusion Center, etc. Key areas of focus: Data management and availability related to Addiction/Opioid Epidemic Training needs in the state for providers Analysis of OCME OD Death data and trends Gap Analysis for overall VDH response by Office and Subject area Collaboration activities with other agencies, partners Policy Needs Workgroup meets approximately every 6 weeks Next meeting: November 2016 http://www.dmas.virginia.gov/ 19